Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 1 , Pages 35-42 , February 2010

Primary gastrointestinal tract mantle cell lymphoma as multiple lymphomatous polyposis

  • Agnes Ruskoné-Fourmestraux, MD, PhD

      Affiliations

    • Department of Gastroenterology, Hôpital Saint-Antoine, ApHp, 184 rue du Faubourg St. Antoine, 75012 Paris, France
    • Corresponding Author InformationCorresponding author. Tel.: +33(1) 49 82 31 70; Fax: +33(1) 49 28 31 88.
    • ,
  • Josée Audouin, MD, PhD

      Affiliations

    • Department of Pathology, Hôtel Dieu, ApHp, Descartes University, Paris, France
    • Tel.: +33(1) 42 34 87 10; Fax: +33(1) 42 34 86 40.

References 

  1. Kodama T, Ohshima K, Nomura K, et al. Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma. Histopathology. 2005;47:467–478
  2. Ruskone-Fourmestraux A, Delmer A, Lavergne A, et al. Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'etude des Lymphomes Digestifs. Gastroenterology. 1997;112:7–16
  3. Foss HD, Stein H. Pathology of intestinal lymphomas. Recent Results Cancer Res. 2000;156:33–41
  4. Crump M, Gospodarowicz M, Shepherd FA. Lymphoma of the gastrointestinal tract. Semin Oncol. 1999;26:324–337
  5. Yatabe Y, Nakamura S, Nakamura T, et al. Multiple polypoid lesions of primary mucosa-associated lymphoid-tissue lymphoma of colon. Histopathology. 1998;32:116–125
  6. Kohno S, Ohshima K, Yoneda S, et al. Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology. 2003;43:135–143
  7. Cornes JS. Multiple lymphomatous polyposis of the gastrointestinal tract. Cancer. 1961;14:249–257
  8. Sheahan DG, Martin F, Baginsky S, et al. Multiple lymphomatous polyposis of the gastrointestinal tract. Cancer. 1971;28:408–425
  9. Ruppert GB, Smith VM. Multiple lymphomatous polyposis of the gastrointestinal tract. Gastrointest Endosc. 1979;25:67–69
  10. Isaacson PG, MacLennan KA, Subbuswamy SG. Multiple lymphomatous polyposis of the gastrointestinal tract. Histopathology. 1984;8:641–656
  11. Fernandes BJ, Amato D, Goldfinger M. Diffuse lymphomatous polyposis of the gastrointestinal tract. A case report with immunohistochemical studies. Gastroenterology. 1985;88:1267–1270
  12. Zuckerman MJ, Pittman DL, Boman D, et al. Multiple lymphomatous polyposis of the gastrointestinal tract with immunologic marker studies. J Clin Gastroenterol. 1986;8:295–300
  13. O'Briain DS, Kennedy MJ, Daly PA, et al. Multiple lymphomatous polyposis of the gastrointestinal tract. A clinicopathologically distinctive form of non-Hodgkin's lymphoma of B-cell centrocytic type. Am J Surg Pathol. 1989;13:691–699
  14. Ohri SK, Keane PF, Sackier JM, et al. Primary rectal lymphoma and malignant lymphomatous polyposis. Two cases illustrating current methods in diagnosis and management. Dis Colon Rectum. 1989;32:1071–1074
  15. Jalleh RP, Semeraro D, Vellacott KD. Cecocolic intussusception in multiple lymphomatous polyposis of the gastrointestinal tract. Report of a case. Dis Colon Rectum. 1990;33:424–426
  16. Erlacher L, Wagner A, Knoflach P, et al. Malignant lymphomatous polyposis of the gastrointestinal tract. Dtsch Med Wochenschr. 1992;117:15–18
  17. Mynster T, Hultberg B, Bulow S. Multiple lymphomatous polyposis of the colon and rectum. Report of a case and review of the literature. Scand J Gastroenterol. 1994;29:545–549
  18. Norum J, Hovde O, Stalsberg H. Multiple lymphomatous polyposis of the gut. J Clin Gastroenterol. 1994;19:132–134
  19. Mahe B, Moreau A, Moreau P, et al. High dose radiochemotherapy followed by autologous stem cell transplantation in four patients with multiple lymphomatous polyposis. Cancer. 1995;75:2742–2746
  20. Michopoulos S, Petraki K, Matsouka C, et al. Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract. J Clin Oncol. 2008;26:1555–1557
  21. Lavergne A, Brouland JP, Launay E, et al. Multiple lymphomatous polyposis of the gastrointestinal tract. An extensive histopathologic and immunohistochemical study of 12 cases. Cancer. 1994;74:3042–3050
  22. Isaacson PG, Spencer J, Wright DH. Classifying primary gut lymphomas. Lancet. 1988;2:1148–1149
  23. Swerdlow SH, Campo E, Seto M, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. In:  Swerdlow SH editors. Lyon: IARC; 2008;p. 229–232
  24. Romaguera JE, Medeiros LJ, Hagemeister FB, et al. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer. 2003;97:586–591
  25. Salar A, Juanpere N, Bellosillo B, et al. Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study. Am J Surg Pathol. 2006;30:1274–1280
  26. Hotta K, Oyama T, Kitamura Y, et al. Mantle cell lymphoma presenting as multiple lymphomatous polyposis spreading widely to the small intestine and diagnosed by double-balloon endoscopy. Endoscopy. 2007;39(Suppl. 1):E347–E348
  27. Hashimoto Y, Nakamura N, Kuze T, et al. Multiple lymphomatous polyposis of the gastrointestinal tract is a heterogenous group that includes mantle cell lymphoma and follicular lymphoma: analysis of somatic mutation of immunoglobulin heavy chain gene variable region. Hum Pathol. 1999;30:581–587
  28. Okazaki K. Multiple lymphomatous polyposis form is common but not specific for mantle cell lymphoma in the gastrointestinal tract. J Gastroenterol. 2004;39:1023–1024
  29. Feller AC, Diebold J. Histopathology of nodal and extranodal non-Hodgkin's lymphomas. Berlin, Heidelberg; 2004.
  30. Fraga M, Lloret E, Sanchez-Verde L, et al. Mucosal mantle cell (centrocytic) lymphomas. Histopathology. 1995;26:413–422
  31. Zucca E, Fontana S, Roggero E, et al. Treatment and prognosis of centrocytic (mantle cell) lymphoma: a retrospective analysis of twenty-six patients treated in one institution. Leuk Lymphoma. 1994;13:105–110
  32. Spencer J, Finn T, Isaacson PG. Human Peyer's patches: an immunohistochemical study. Gut. 1986;27:405–410
  33. Pals ST, Drillenburg P, Dragosics B, et al. Expression of the mucosal homing receptor alpha 4 beta 7 in malignant lymphomatous polyposis of the intestine. Gastroenterology. 1994;107:1519–1523
  34. Geissmann F, Ruskone-Fourmestraux A, Hermine O, et al. Homing receptor alpha4beta7 integrin expression predicts digestive tract involvement in mantle cell lymphoma. Am J Pathol. 1998;153:1701–1705
  35. Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol. 2005;131:29–38
  36. Garcia M, Romaguera JE, Inamdar KV, et al. Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine. Cancer. 2009;115:1041–1048
  37. Williams ME, Nichols GE, Swerdlow SH, et al. In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma. Ann Oncol. 1995;6:297–299
  38. Du MQ, Diss TC, Xu CF, et al. Ongoing immunoglobulin gene mutations in mantle cell lymphomas. Br J Haematol. 1997;96:124–131
  39. Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas. (author's transl) Strahlentherapie. 1977;153:218–221
  40. Lenz G, Dreyling M, Hoster E, et al. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol. 2005;23:1984–1992
  41. Murali S, Winton E, Waller EK, et al. Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma. Bone Marrow Transplant. 2008;42:529–534
  42. Romaguera JE, Fayad L, Rodriguez MA, et al. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. J Clin Oncol. 2005;23:7013–7023
  43. Geisler CH, Kolstad A, Laurell A, et al. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood. 2008;112:2687–2693
  44. Gianni AM, Magni M, Martelli M, et al. Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen). Blood. 2003;102:749–755
  45. Witzig TE. Current treatment approaches for mantle-cell lymphoma. J Clin Oncol. 2005;23:6409–6414
  46. Wiernik PH, Lossos IS, Tuscano JM, et al. Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2008;26:4952–4957

PII: S1521-6918(09)00154-1

doi: 10.1016/j.bpg.2009.12.001

Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 1 , Pages 35-42 , February 2010

Article Tools

* Image Usage & Resolution